📖
Real-world outcomes of datopotamab deruxtecan after trastuzumab deruxtecan in hormone receptor-positive, HER2-negative metastatic breast cancer.
Aoyama Y, Ozaki Y, Kuno M, Kizawa R, Masuda J, Nishimura M, Kurata M, Inagaki L, Hosonaga M, Fukada I, Maeda T, Yoshida K, Yamashita N, Kobayashi T, Takano T, Ueno T

Real-world outcomes of datopotamab deruxtecan after trastuzumab deruxtecan in hormone receptor-positive, HER2-negative metastatic breast cancer.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Breast Cancer.

Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Real-world outcomes of datopotamab deruxtecan after trastuzumab deruxtecan in hormone receptor-positive, HER2-negative metastatic breast cancer.
Author / Organization Aoyama Y, Ozaki Y, Kuno M, Kizawa R, Masuda J, Nishimura M, Kurata M, Inagaki L, Hosonaga M, Fukada I, Maeda T, Yoshida K, Yamashita N, Kobayashi T, Takano T, Ueno T
Subject & Discipline Breast Cancer
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-6110
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »